Key Details
Price
$360.97PE Ratio
31.61Annual ROE
59.83%Beta
1.16Events Calendar
Next earnings date:
Feb 10, 2025Recent quarterly earnings:
Oct 21, 2024Recent annual earnings:
Feb 12, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Medpace has shown strong financial results, with a revenue increase of 495.26% from the second quarter of 2016 to the third quarter of 2024. The company's current return on equity (ROE) stands at 54.08%, and it has successfully targeted small and mid-sized businesses, gaining a competitive edge in this area. Even though Medpace has faced significant cancellations in its backlog, it remains a robust company, achieving a growth rate of 9.81% from 2023 to the third quarter of 2024.
At the end of the last trading day, Medpace (MEDP) was priced at $343.38, which represents a decrease of 1.65% compared to the day before.
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
In the most recent trading session, Medpace (MEDP) finished at $350.37, which is an increase of 1.83% compared to the day before.
LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national firm that represents shareholders, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements and/or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national firm specializing in shareholder rights, is looking into claims for investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) regarding possible violations of securities laws. The investigation is centered on whether the Company made false or misleading statements or did not share important information with investors.
FAQ
- What is the ticker symbol for Medpace Holdings?
- Does Medpace Holdings pay dividends?
- What sector is Medpace Holdings in?
- What industry is Medpace Holdings in?
- What country is Medpace Holdings based in?
- When did Medpace Holdings go public?
- Is Medpace Holdings in the S&P 500?
- Is Medpace Holdings in the NASDAQ 100?
- Is Medpace Holdings in the Dow Jones?
- When was Medpace Holdings's last earnings report?
- When does Medpace Holdings report earnings?
- Should I buy Medpace Holdings stock now?